This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Role of Oral Sucrose in Reducing the Pain to Orogastric Tube Insertion in Preterm Neonates

This study has been completed.
Information provided by:
Lady Hardinge Medical College Identifier:
First received: July 29, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted

RESEARCH HYPOTHESIS Orally administered sucrose 2 minutes prior to the procedure of OGT insertion reduces pain associated with the procedure.


To study the effect of 24% oral sucrose on decreasing the painful response to orogastric tube insertion .

Condition Intervention Phase
Pain in Preterm Neonates Drug: Sucrose Drug: Double distilled water Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Study to Assess the Role of Oral Sucrose in Reducing the Pain to Orogastric Tube Insertion in Preterm Neonates

Resource links provided by NLM:

Further study details as provided by Lady Hardinge Medical College:

Primary Outcome Measures:
  • Painful response as assessed by PIPP Scale [ Time Frame: Pre procedure,Intra procedure,post 30 sec,post 1 min,post 2 minutes ]

Secondary Outcome Measures:
  • Maximum heart rate and minimum oxygen saturation [ Time Frame: pre procedure,intra procedure,post 30 seconds,post 1 minute,post 2 minute ]

Enrollment: 120
Study Start Date: January 2008
Study Completion Date: April 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Sucrose
1 ml of 24% sucrose was administered 2 minutes before the procedure
Drug: Sucrose
1 ml of 24% sucrose was administered 2 minutes prior to the procedure
Other Name: 24%Sucrose
Placebo Comparator: Placebo
Double distilled water
Drug: Double distilled water
1 ml of double distilled water (Placebo) was administered 2 minutes prior to the procedure

  Show Detailed Description


Ages Eligible for Study:   up to 167 Hours   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All pre-terms ( < 37 weeks of gestational age.)
  • Within the first 7 days postnatal days (</=168 hours).
  • Clinically stable from respiratory, hemodynamic and metabolic point of view.
  • Who have not received any painful stimulus at least 30 minutes prior to the intervention.
  • Requiring routine orogastric tube insertion within the first 7 days of life.
  • Only the first attempt at putting OGT in controlled NICU environment will be considered

Exclusion Criteria:

The neonates with the following characteristics will be excluded from the study:

  • Neonates requiring ventilatory support.
  • Neonates requiring oxygen supplementation.
  • Having any facial congenital anomalies.
  • Having any neurological impairment.
  • Receiving opiates or born to mothers receiving opiates.
  • New born babies to whom muscle relaxants, sedatives and analgesics have been administered.
  • With grade 3 and 4 IVH.
  • With major congenital anomalies
  • Any history of birth trauma especially involving face or scalp (including cephalhematoma/ subgaleal bleed).
  • Face presentation.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00949104

Lady Hardinge Medical College
New Delhi, India, 110001
Sponsors and Collaborators
Lady Hardinge Medical College
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: DR Vikram Datta, Lady Hardinge Medical College,New Delhi Identifier: NCT00949104     History of Changes
Other Study ID Numbers: OGTPAIN
Study First Received: July 29, 2009
Last Updated: July 29, 2009

Keywords provided by Lady Hardinge Medical College:
orogastric tube

Additional relevant MeSH terms:
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications processed this record on August 18, 2017